← Open Payments lookup

KEYAMO OMOKURU: Open Payments

NPI 1295066694 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,009 in 59 payments from 11 companies in 2025. Trend: 2023 $1,755 · 2024 $1,313 · 2025 $1,009

Food & beverage: $897Education: $111
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$300
ABBVIE INC.27$193
Teva Pharmaceuticals USA, Inc.2$135
Alkermes, Inc.3$72
Neurocrine BioSciences, Inc.4$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$68
Janssen Pharmaceuticals, Inc3$66
Axsome Therapeutics, Inc.2$47
Vanda Pharmaceuticals Inc.1$24
Otsuka America Pharmaceutical, Inc.1$20

Products named: COBENFY, VRAYLAR, INGREZZA, CAPLYTA, INVEGA SUSTENNA, Auvelity, LYBALVI, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.